CureVac logo

CureVac Employee Directory

Biotechnology ResearchBaden-Württemberg, Germany501-1000 Employees

CureVac is a multinational biotechnology company focused on messenger RNA (mRNA) technology for human medicine. It has developed and refined foundational approaches that supported the production of mRNA vaccines used to address COVID-19 and is pursuing additional therapeutic applications of mRNA in areas with high medical need. The company is pursuing both off-the-shelf and personalized cancer vaccine candidates, as well as prophylactic vaccines and approaches that prompt the body to generate therapeutic proteins, aided by omics and computational tools. Headquartered in Tübingen, Baden-Württemberg, CureVac operates sites in the Netherlands, Belgium, Switzerland, and the United States.

Founded in 2000, it belongs to the biotechnology research sector and maintains an international footprint through its multiple sites. In 2026, CureVac filed a patent-infringement lawsuit against Moderna in Delaware federal court over mRNA vaccine technology.

Find CureVac employees' phone numbers or email addresses

CureVac Global Highlights

Location
Employees

Europe
588

Minus sign iconPlus sign icon
  • Germany
    567
  • Belgium
    8
  • Netherlands
    5
  • United Kingdom Of Great Britain And Northern Ireland
    3
  • Austria
    2
  • Hungary
    1
  • France
    1
  • Switzerland
    1

North America
11

Minus sign iconPlus sign icon
  • United States Of America
    11

South America
3

Minus sign iconPlus sign icon
  • Argentina
    3

Africa
1

Minus sign iconPlus sign icon
  • Algeria
    1

CureVac's Leadership

  • Vice President Oncology R&d at CureVac
    M. Z.
    Vice President Oncology R&d
  • Vp Digital And Data For R&d at CureVac
    N. V. B.
    Vp Digital And Data For R&d
  • Vp Technical Development at CureVac
    M. S.
    Vp Technical Development
  • Vp Manufacturing at CureVac
    Y. G.
    Vp Manufacturing
  • Vice President Procurement at CureVac
    M. G.
    Vice President Procurement
  • Vice President Patents at CureVac
    M. D.
    Vice President Patents
  • Head Of Qa External Manufacturing/Cmo at CureVac
    O. J.
    Head Of Qa External Manufacturing/Cmo
  • Head Of Procurement Capex & Transformation Leader at CureVac
    M. P.
    Head Of Procurement Capex & Transformation Leader

CureVac Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Engineering
  • Program & Project Management
  • Quality Assurance
  • Information Technology
  • Other
  • Education
  • Biotechnology
  • Administrative
  • Legal
  • Human Resources

Contact profiles from CureVac

Name
Title
Contact
Location
Last Update
  • Head Of Qa External Manufacturing/Cmo at CureVac
    O. J.
    Head Of Qa External Manufacturing/Cmo
    France, Hauts-de-France
    Sep 04, 2026
  • Executive Assistant To Coo at CureVac
    L. M.
    Executive Assistant To Coo
    Germany, Baden-Württemberg
    Jul 06, 2026
  • Senior Vice President | Oncology Head | Translational Oncology | Global Drug Development at CureVac
    F. F. L.
    Senior Vice President | Oncology Head | Translational Oncology | Global Drug Development
    Belgium
    May 04, 2026
  • Vice President Oncology R&d at CureVac
    M. Z.
    Vice President Oncology R&d
    Austria, Vienna
    May 04, 2026
  • Vp Digital And Data For R&d at CureVac
    N. V. B.
    Vp Digital And Data For R&d
    Belgium, Flanders
    Aug 18, 2026
  • Senior Vice President Technology at CureVac
    P. B.
    Senior Vice President Technology
    Germany, Baden-Württemberg
    Apr 22, 2026
  • Senior Director – Head Of Supply Chain Management at CureVac
    F. P.
    Senior Director – Head Of Supply Chain Management
    Aug 30, 2026
  • Head Of Procurement Capex & Transformation Leader at CureVac
    M. P.
    Head Of Procurement Capex & Transformation Leader
    Germany
    May 04, 2026
  • Vp Technical Development at CureVac
    M. S.
    Vp Technical Development
    Germany, Baden-Württemberg
    Apr 22, 2026
  • Senior Vice President Clinical Development at CureVac
    U. G.
    Senior Vice President Clinical Development
    Apr 22, 2026

Frequently Asked Questions

What is CureVac known for?

Minus sign iconPlus sign icon
CureVac was founded in 2000 and operates in the Biotechnology Research industry. You can contact CureVac's main corporate office by phone at . Explore CureVac's company overview page for more information.

What is CureVac's most common email format?

Minus sign iconPlus sign icon
CureVac employees' email format typically follows the pattern of First.Last@curevac.com. Trying to find reliable and up-to-date employee contact data? Find more CureVac email formats with LeadIQ.

How many employees does CureVac have currently?

Minus sign iconPlus sign icon
CureVac has approximately 665 employees as of August 2026. These team members are located across 4 continents, including Europe, North America and South America.

Who are CureVac's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, CureVac's key employees include:

  • Vice President Oncology R&d: M. Z.
  • Vp Digital And Data For R&d: N. V. B.
  • Vp Technical Development: M. S.
  • Vp Manufacturing: Y. G.
  • Vice President Procurement: M. G.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.